Adalimumab 40 mg sc every other week ( DrugBank: Adalimumab )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
271	Ankylosing spondylitis	1

271. Ankylosing spondylitis

---

Clinical trials : 563 /  Drugs : 372 - (DrugBank : 72) / Drug target genes : 41 - Drug target pathways : 145

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00235105 (ClinicalTrials.gov)	March 2005	6/10/2005	D2E7-Early AS	Adalimumab in Early Axial Spondyloarthritis (Without Radiological Sacroiliitis): Placebo Controlled Phase Over 3 Months Followed by a 9 Months Open Extension Phase	Ankylosing Spondylitis	Drug: Adalimumab 40 mg sc every other week	Charite University, Berlin, Germany	Abbott	Active, not recruiting	18 Years	N/A	Both	46	Phase 2/Phase 3	Germany